Augustine Lawlor
Chairman
Gyre Therapeutics, Inc. (GYRE)Board Member
Gyre Therapeutics, Inc. (GYRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Augustine Lawlor
Augustine Lawlor is recorded as Chairman and Board Member at Gyre Therapeutics, Inc. (GYRE). Gyre Therapeutics, Inc. reported in an 8-K filed October 30, 2023 that Augustine Lawlor resigned as Board, effective October 30, 2023. Gyre Therapeutics, Inc. reported in an 8-K filed December 27, 2022 that Augustine Lawlor was appointed Director, effective December 26, 2022.
“On October 30, 2023, Augustine Lawlor and Andrea Hunt each notified the board of directors of Catalyst of his or her intention to resign from the Board and committees of the Board on which he or she served, effectively immediately.”
“The Board appointed Mr. Augustine Lawlor to serve as a Class I director with a term expiring at Catalyst's 2025 annual meeting of the stockholders and until such time as his successor is duly elected and qualified, or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-26–present
-
Current
Start not stated–present
-
2022-12-26–2023-10-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Gyre Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Charles Wu CEO, Board Member
- Dr. Han Ying CEO
- Dr. Ying Luo CEO, Board Member
- Ping Zhang CEO, Board Member
- Ying Luo CEO, Board Member
- Ying Luo, Ph.D. CEO, Board Member
- Songjiang Ma Chairman, Board Member
- Clinton Musil CFO
- Fletcher Payne CFO
- Ruoyu Chen CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.